Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 5/2007

01.10.2007 | Original Paper

A comparison of myocardial perfusion and rejection in cardiac transplant patients

verfasst von: Andrew L. Rivard, Cory M. Swingen, Donnevan Blake, Andrea S. Huang, Pooja Kanth, Grete F. Thomsen, Erin J. Cordova, Leslie W. Miller, Richard W. Bianco, Norbert Wilke

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Although histological evaluation of the cardiac tissue is the current gold standard for evaluation of rejection, we hypothesized that cardiac perfusion MRI is a safe non-invasive method that correlates tissue blood flow changes with biopsy proven rejection in the cardiac transplant patient.

Materials and methods

In a retrospective study from 1984–2001, 83 patients underwent 135 MR Gd-DTPA imaging studies. In 8 patients (9%), biopsies graded 2 or higher (by ISHLT criteria) provided evidence of rejection. Patients were age and sex matched to 11 non-rejected controls for imaging analysis. Time–signal intensity curves generated for a mid-ventricle LV short axis slice during rest and adenosine stress allowed determination of myocardial blood flow (MBF, ml/min/gm). ROC curve analysis by SPSS allowed estimation of sensitivity and specificity.

Results

At rest, there was no difference in MBF between patients with prior rejection vs. those without (1.18 ± 0.26 vs. 1.16 ± 0.29). At stress there was a decrease in MBF for patients with prior rejection episodes (3.27 ± 0.74) compared to no rejection (3.60 ± 0.72), P = 0.067). The area under the ROC curve was 0.82, with specificity and sensitivity of 75% and 81%, respectively.

Conclusion

This study suggests that perfusion MR imaging can be used in assessing the cardiac transplant patient for rejection related microvascular changes. The high specificity and sensitivity recorded from the ROC curve illustrates the potential utility of this diagnostic test for future studies.
Literatur
1.
Zurück zum Zitat Evans RW, Williams GE, Baron HM et al (2005) The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant 5(6):1553–1558PubMedCrossRef Evans RW, Williams GE, Baron HM et al (2005) The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant 5(6):1553–1558PubMedCrossRef
2.
Zurück zum Zitat Kirklin JK, Young JB, McGiffin D (2002) Heart transplantation. Churchill Livingstone, New York Kirklin JK, Young JB, McGiffin D (2002) Heart transplantation. Churchill Livingstone, New York
3.
Zurück zum Zitat Mehra MR, Uber PA, Uber WE, Park MH, Scott RL (2002) Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection. Curr Opin Cardiol 17(2):131–136PubMedCrossRef Mehra MR, Uber PA, Uber WE, Park MH, Scott RL (2002) Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection. Curr Opin Cardiol 17(2):131–136PubMedCrossRef
4.
Zurück zum Zitat Marie PY, Angioi M, Carteaux JP et al (2001) Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 37(3):825–831PubMedCrossRef Marie PY, Angioi M, Carteaux JP et al (2001) Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 37(3):825–831PubMedCrossRef
5.
Zurück zum Zitat Bergsland J, Carr EA Jr, Carroll M, Feldman MJ, Kung H, Wright JR (1989) Uptake of perfusion imaging agents by transplanted hearts: an experimental study in rats. J Surg Res 46(2):184–186PubMedCrossRef Bergsland J, Carr EA Jr, Carroll M, Feldman MJ, Kung H, Wright JR (1989) Uptake of perfusion imaging agents by transplanted hearts: an experimental study in rats. J Surg Res 46(2):184–186PubMedCrossRef
6.
Zurück zum Zitat Fraser CD Jr, Chacko VP, Jacobus WE et al (1990) Early phosphorus 31 nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts. J Heart Transplant 9(3 Pt 1):197–204PubMed Fraser CD Jr, Chacko VP, Jacobus WE et al (1990) Early phosphorus 31 nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts. J Heart Transplant 9(3 Pt 1):197–204PubMed
7.
Zurück zum Zitat Laczkovics A, Grabenwoger F, Teufelsbauer H, Dock W, Wollenek G, Wolner E (1988) Noninvasive assessment of acute rejection after orthotopic heart transplantation: value of changes in cardiac volume and cardiothoracic ratio. J Cardiovasc Surg (Torino) 29(5):582–586 Laczkovics A, Grabenwoger F, Teufelsbauer H, Dock W, Wollenek G, Wolner E (1988) Noninvasive assessment of acute rejection after orthotopic heart transplantation: value of changes in cardiac volume and cardiothoracic ratio. J Cardiovasc Surg (Torino) 29(5):582–586
8.
Zurück zum Zitat Lieback E, Nawrocki M, Meyer R, Bellach J, Warnecke H, Cohnert T (1992) The clinical value of ultrasonic tissue characterization in the management of heart transplant patients. Transpl Int 5(Suppl 1):S231–S233PubMed Lieback E, Nawrocki M, Meyer R, Bellach J, Warnecke H, Cohnert T (1992) The clinical value of ultrasonic tissue characterization in the management of heart transplant patients. Transpl Int 5(Suppl 1):S231–S233PubMed
9.
Zurück zum Zitat Phillips M, Boehmer JP, Cataneo RN et al (2004) Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study). J Heart Lung Transplant 23(6):701–708PubMedCrossRef Phillips M, Boehmer JP, Cataneo RN et al (2004) Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study). J Heart Lung Transplant 23(6):701–708PubMedCrossRef
10.
Zurück zum Zitat Roodman ST, Miller LW, Tsai CC (1988) Role of interleukin 2 receptors in immunologic monitoring following cardiac transplantation. Transplantation 45(6):1050–1056PubMedCrossRef Roodman ST, Miller LW, Tsai CC (1988) Role of interleukin 2 receptors in immunologic monitoring following cardiac transplantation. Transplantation 45(6):1050–1056PubMedCrossRef
11.
Zurück zum Zitat Spiegelhalter DJ, Stovin PG (1983) An analysis of repeated biopsies following cardiac transplantation. Stat Med 2(1):33–40PubMedCrossRef Spiegelhalter DJ, Stovin PG (1983) An analysis of repeated biopsies following cardiac transplantation. Stat Med 2(1):33–40PubMedCrossRef
12.
Zurück zum Zitat Schoels M, Dengler TJ, Richter R, Meuer SC, Giese T (2004) Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells. Clin Transplant 18(5):513–517PubMedCrossRef Schoels M, Dengler TJ, Richter R, Meuer SC, Giese T (2004) Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells. Clin Transplant 18(5):513–517PubMedCrossRef
13.
Zurück zum Zitat Dodd DA, Brady LD, Carden KA, Frist WH, Boucek MM, Boucek RJ Jr (1993) Pattern of echocardiographic abnormalities with acute cardiac allograft rejection in adults: correlation with endomyocardial biopsy. J Heart Lung Transplant 12(6 Pt 1):1009–1017PubMed Dodd DA, Brady LD, Carden KA, Frist WH, Boucek MM, Boucek RJ Jr (1993) Pattern of echocardiographic abnormalities with acute cardiac allograft rejection in adults: correlation with endomyocardial biopsy. J Heart Lung Transplant 12(6 Pt 1):1009–1017PubMed
14.
Zurück zum Zitat Constantine G, Shan K, Flamm SD, Sivananthan MU (2004) Role of MRI in clinical cardiology. Lancet 363(9427):2162–2171PubMedCrossRef Constantine G, Shan K, Flamm SD, Sivananthan MU (2004) Role of MRI in clinical cardiology. Lancet 363(9427):2162–2171PubMedCrossRef
15.
Zurück zum Zitat Sasaguri S, LaRaia PJ, Fabri BM et al (1985) Early detection of cardiac allograft rejection with proton nuclear magnetic resonance. Circulation 72(3 Pt 2):II231–II236PubMed Sasaguri S, LaRaia PJ, Fabri BM et al (1985) Early detection of cardiac allograft rejection with proton nuclear magnetic resonance. Circulation 72(3 Pt 2):II231–II236PubMed
16.
Zurück zum Zitat Aherne T, Tscholakoff D, Finkbeiner W et al (1986) Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression. Circulation 74(1):145–156PubMed Aherne T, Tscholakoff D, Finkbeiner W et al (1986) Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression. Circulation 74(1):145–156PubMed
17.
Zurück zum Zitat Aherne T, Yee ES, Tscholakoff D, Gollin G, Higgins C, Ebert PA (1988) Diagnosis of acute and chronic cardiac rejection by magnetic resonance imaging: a non-invasive in-vivo study. J Cardiovasc Surg (Torino) 29(5):587–590 Aherne T, Yee ES, Tscholakoff D, Gollin G, Higgins C, Ebert PA (1988) Diagnosis of acute and chronic cardiac rejection by magnetic resonance imaging: a non-invasive in-vivo study. J Cardiovasc Surg (Torino) 29(5):587–590
18.
Zurück zum Zitat Wisenberg G, Pflugfelder PW, Kostuk WJ, McKenzie FN, Prato FS (1987) Diagnostic applicability of magnetic resonance imaging in assessing human cardiac allograft rejection. Am J Cardiol 60(1):130–136PubMedCrossRef Wisenberg G, Pflugfelder PW, Kostuk WJ, McKenzie FN, Prato FS (1987) Diagnostic applicability of magnetic resonance imaging in assessing human cardiac allograft rejection. Am J Cardiol 60(1):130–136PubMedCrossRef
19.
Zurück zum Zitat Nishimura T, Sada M, Sasaki H et al (1987) Identification of cardiac rejection with magnetic resonance imaging in heterotopic heart transplantation model. Heart Vessels 3(3):135–140PubMedCrossRef Nishimura T, Sada M, Sasaki H et al (1987) Identification of cardiac rejection with magnetic resonance imaging in heterotopic heart transplantation model. Heart Vessels 3(3):135–140PubMedCrossRef
20.
Zurück zum Zitat Doornbos J, Verwey H, Essed CE, Balk AH, de Roos A (1990) MR imaging in assessment of cardiac transplant rejection in humans. J Comput Assist Tomogr 14(1):77–81PubMedCrossRef Doornbos J, Verwey H, Essed CE, Balk AH, de Roos A (1990) MR imaging in assessment of cardiac transplant rejection in humans. J Comput Assist Tomogr 14(1):77–81PubMedCrossRef
21.
Zurück zum Zitat Smart FW, Young JB, Weilbaecher D, Kleiman NS, Wendt RE III, Johnston DL (1993) Magnetic resonance imaging for assessment of tissue rejection after heterotopic heart transplantation. J Heart Lung Transplant 12(3):403–410PubMed Smart FW, Young JB, Weilbaecher D, Kleiman NS, Wendt RE III, Johnston DL (1993) Magnetic resonance imaging for assessment of tissue rejection after heterotopic heart transplantation. J Heart Lung Transplant 12(3):403–410PubMed
22.
Zurück zum Zitat Walpoth BH, Muller MF, Celik B et al (1998) Assessment of cardiac rejection by MR-imaging and MR-spectroscopy. Eur J Cardiothorac Surg 14(4):426–430PubMedCrossRef Walpoth BH, Muller MF, Celik B et al (1998) Assessment of cardiac rejection by MR-imaging and MR-spectroscopy. Eur J Cardiothorac Surg 14(4):426–430PubMedCrossRef
23.
Zurück zum Zitat Muehling OM, Wilke NM, Panse P et al (2003) Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 42(6):1054–1060PubMedCrossRef Muehling OM, Wilke NM, Panse P et al (2003) Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 42(6):1054–1060PubMedCrossRef
24.
Zurück zum Zitat Almenar L, Igual B, Martinez-Dolz L et al (2003) Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc 35(5):1962–1964PubMedCrossRef Almenar L, Igual B, Martinez-Dolz L et al (2003) Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc 35(5):1962–1964PubMedCrossRef
25.
Zurück zum Zitat Mousseaux E, Farge D, Guillemain R et al (1993) Assessing human cardiac allograft rejection using MRI with Gd-DOTA. J Comput Assist Tomogr 17(2):237–244PubMedCrossRef Mousseaux E, Farge D, Guillemain R et al (1993) Assessing human cardiac allograft rejection using MRI with Gd-DOTA. J Comput Assist Tomogr 17(2):237–244PubMedCrossRef
26.
Zurück zum Zitat Jerosch-Herold M, Swingen C, Seethamraju RT (2002) Myocardial blood flow quantification with MRI by model-independent deconvolution. Med Phys 29(5):886–897PubMedCrossRef Jerosch-Herold M, Swingen C, Seethamraju RT (2002) Myocardial blood flow quantification with MRI by model-independent deconvolution. Med Phys 29(5):886–897PubMedCrossRef
27.
Zurück zum Zitat Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE (2004) Analysis of myocardial perfusion MRI. J Magn Reson Imaging 19(6):758–770PubMedCrossRef Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE (2004) Analysis of myocardial perfusion MRI. J Magn Reson Imaging 19(6):758–770PubMedCrossRef
28.
Zurück zum Zitat Jerosch-Herold M, Wilke N, Stillman AE (1998) Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 25(1):73–84PubMedCrossRef Jerosch-Herold M, Wilke N, Stillman AE (1998) Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 25(1):73–84PubMedCrossRef
29.
Zurück zum Zitat Kroll K, Wilke N, Jerosch-Herold M et al (1996) Modeling regional myocardial flows from residue functions of an intravascular indicator. Am J Physiol 271(4 Pt 2):H1643–H1655PubMed Kroll K, Wilke N, Jerosch-Herold M et al (1996) Modeling regional myocardial flows from residue functions of an intravascular indicator. Am J Physiol 271(4 Pt 2):H1643–H1655PubMed
30.
Zurück zum Zitat Wilke N, Jerosch-Herold M, Wang Y, et al (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204(2):373–384PubMed Wilke N, Jerosch-Herold M, Wang Y, et al (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204(2):373–384PubMed
31.
Zurück zum Zitat Deng MC, Bell S, Huie P et al (1995) Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. Circulation 91(6):1647–1654 Deng MC, Bell S, Huie P et al (1995) Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. Circulation 91(6):1647–1654
32.
Zurück zum Zitat Johansson L, Johnsson C, Penno E, Bjornerud A, Ahlstrom H (2002) Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent – experimental study in the rat. Radiology 225(1):97–103PubMedCrossRef Johansson L, Johnsson C, Penno E, Bjornerud A, Ahlstrom H (2002) Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent – experimental study in the rat. Radiology 225(1):97–103PubMedCrossRef
Metadaten
Titel
A comparison of myocardial perfusion and rejection in cardiac transplant patients
verfasst von
Andrew L. Rivard
Cory M. Swingen
Donnevan Blake
Andrea S. Huang
Pooja Kanth
Grete F. Thomsen
Erin J. Cordova
Leslie W. Miller
Richard W. Bianco
Norbert Wilke
Publikationsdatum
01.10.2007
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 5/2007
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-006-9184-6

Weitere Artikel der Ausgabe 5/2007

The International Journal of Cardiovascular Imaging 5/2007 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.